NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which drug is indicated to improve walking in MS patients?

Ampyra
Benlysta
Ponvory
Kesimpta

The correct answer is: Ampyra

Ampyra is a drug that is indicated to improve walking in MS patients. Ampyra, also known as dalfampridine, is a potassium channel blocker that helps to improve nerve conduction and function. It is specifically approved to improve walking speed in MS patients. The other options, Benlysta, Ponvory, and Kesimpta, are not indicated for this purpose. Benlysta is used to treat lupus, while Ponvory is used to treat relapsing forms of MS, and Kesimpta is used to treat relapsing forms of MS as well. These drugs may have other benefits for MS patients, but they are not specifically indicated to improve walking. Therefore, Ampyra is the correct answer.